Patent Assignment
Reel/Frame 059820/0089
Corrective Assignment to Correct the Application Number 16907132 Previously Recorded at Reel: 058217 Frame: 0169. Assignor(S) Hereby Confirms the Assignment .
Recorded: 2022-04-28
Pages: 4
Assignor
KERROUCHE, NABIL
Executed: 2018-03-28
Assignee
NESTLE SKIN HEALTH SA
AVENUE GRATTA-PAILLE 2, LAUSANNE, 1018, SWITZERLAND
Covered Property
(1)
Nemolizumab in the Treatment of Atopic Dermatitis with Moderate to Severe Excoriation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0169 →
Assignment of Assignor's Interest
Nov 27, 2021
From: KERROUCHE, NABIL
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 058217/0184 →
Assignment of Assignor's Interest
Nov 27, 2021
From: HIROKAWA, KEIKO
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 058217/0187 →
Assignment of Assignor's Interest
Nov 27, 2021
From: MIHARA, RYOSUKE
To: CHUGAI SEIYAKU KABUSHIKI KAISHA
Reel/Frame 058217/0192 →
Change of Name
Nov 27, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 058217/0201 →
Change of Address
Jun 27, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 061113/0710 →